Harlan Krumholz & Howard Forman, Yale Medical School | Health & Veritas Podcast. In a Wide-Ranging Interview, Dr. Jerry Avorn Explains How the Drug Marketing Machine Works — and How to Counter It Source: Health & Veritas, Yale School of Management, Episode 195, November 13, 2025 In a November 2025 episode of Health & Veritas — the Yale School of Management podcast hosted by physicians Howard Forman and Harlan Krumholz — Jerry Avorn, MD, sat down for an extended conversation c

From NPR's On Point. By Meghna Chakrabarti. In this October 2025 episode of WBUR's On Point, Dr. Jerry Avorn joins host Meghna Chakrabarti and Sarah Emond, president and CEO of the Institute for Clinical and Economic Review (ICER), to dissect the Trump administration's TrumpRx initiative, analyze the deals struck with Pfizer and AstraZeneca, and explain why the United States pays dramatically more for prescription drugs than every other wealthy nation on earth. Why Americans

From The People’s Pharmacy. Abstract "Americans spend more on drugs and have less to show for it than people in other countries. The FDA used to be the envy of the world. Has it been captured by the pharmaceutical industry it's supposed to regulate?" In this wide-ranging episode of The People's Pharmacy — one of the most substantive and practically useful interviews in the archive — Dr. Jerry Avorn joins hosts Joe and Terry Graedon for a 70-minute conversation covering the er

From the JAMA Health Forum. By Helen Mooney, Kirsten Austad, Eric G. Campbell, Jerry Avorn, MD, Zhigang Lu, Aaron S. Kesselheim, MD, JD, MPH. SUMMARY: This JAMA Health Forum survey study examines how medical students' and residents' interactions with and attitudes toward the pharmaceutical industry changed over a 13-year period from 2011 to 2024. The research team — which includes Avorn, a founding figure in academic detailing research — surveyed the same population of train

From Kaiser Permanente Institute for Health Policy Forum. Teaser/Abstract "During the Kaiser Permanente Institute for Health Policy forum, experts discussed emerging solutions to address policies and tactics that currently enable high drug prices." Source: Kaiser Permanente Institute for Health Policy, "A Path to Fair Drug Pricing: Examining Competition, Value, and Access." In-person forum, Washington, DC, July 15, 2025. Video published July 31, 2025. Duration of full segment